ArticleFrontiers in immunology2021

Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2.

Roshan Kumar Roy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.